Activation of the IL-10 gene promoter following photodynamic therapy of murine keratinocytes

Photochemistry and Photobiology

Volumn 73, Issue 2, 2001, Pages 170-177

  Gollnick, Sandra O ^a   Lee, Benjamin Y ^a   Vaughan, Lurine ^a   Owczarczak, Barbara ^a   Henderson, Barbara W ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; INTERLEUKIN 10; MESSENGER RNA; PHOTOFRIN; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; DRUG EFFECT; KERATINOCYTE; NONHUMAN; PHOTODYNAMIC THERAPY; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RNA STABILITY; ULTRAVIOLET B RADIATION;

ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; INTERLEUKIN-10; KERATINOCYTES; MICE; PHOTOCHEMOTHERAPY; PROMOTER REGIONS (GENETICS); RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; ULTRAVIOLET RAYS;

ANIMALIA; MURINAE;

EID: 0035263184     PISSN: 00318655     EISSN: None     Source Type: Journal    
DOI: 10.1562/0031-8655(2001)073<0170:AOTIGP>2.0.CO;2     Document Type: Article

References (53)

1. Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. J. Natl. Cancer Inst. 90, 889-905.
2. Ratkay, L. G., R. K. Chowdhary, A. Iamaroon, A. M. Richter, H. C. Neyndorff, E. C. Keystone, J. D. Waterfield and J. G. Levy (1998) Amelioration of antigen-induced arthritis in rabbits by induction of apoptosis of inflammatory cells with local application of transdermal photodynamic therapy. Arthritis Rheum. 41, 525-534.
3. Trauner, K., R. Gandouredwards, M. Bamberf, N. S. Nishioka, T. Flotte, S. Autry and T. Hasan (1998) Influence of light delivery on photodynamic synovectomy in an antigen-induced arthritis model for rheumatoid arthritis. Lasers Surg. Med. 22, 147-156.
4. Leong, S., A. H. Chan, J. G. Levy and D. W. C. Hunt (1996) Transcutaneous photodynamic therapy alters the development of an adoptively transferred form of murine experimentall autoimmune encephalomyelitis. Photochem. Photobiol. 64, 751-757.
5. Boehncke, W. H., T. Elshorst-Schmidt and R. Kaufmann (2000) Systemic photodynamic therapy is a safe and effective treatment for psoriasis. Arch. Dermatol. 136, 271-272.
6. Fine, S. L. (1999) Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration. Arch. Ophthalmol. 117, 1400-1402.
7. Hryhorenko, E. A, A. R. Oseroff, J. Morgan and K. Rittenhouse-Diakun (1999) Deletion of alloantigen-activated cells by aminolevulinic acid-based photodynamic therapy. Photochem. Photobiol. 69, 560-565.
8. Chowdhary, R. K., L. G. Ratkay, H. C. Neyndorff, A. M. Richter, M. Obochi, J. D. Waterfield and J. G. Levy (1994) The use of transcutaneous photodynamic therapy in the prevention of adjuvant-enhanced arthritis in mlr/lpr mice. Clin. Immunol. Immunopathol. 72, 255-263.
9. Hunt, D. W. C., H. Jiang, D. J. Granville, A. H. Chan, S. Leong and J. G. Levy (1999) Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology 41, 31-44.
10. King, D. E., H. Jiang, G. Simkin, M. Obochi, J. G. Levy and D. W. C. Hunt (1999) Photodynamic alteration of the surface receptor expression pattern of murine splenic dendritic cells. Scand. J. Immunol. 49, 184-192.
11. Gollnick, S. O., X. Liu, B. Owczarczak, D. A. Musser and B. W. Henderson (1997) Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res. 57, 3904-3909.
12. Musser, D. A., S. O. Gollnick, A. R. Oseroff and B. W. Henderson (1998) Photodynamic therapy (PDT) induces long term suppression of CHS which is correlated with systemic and localized expression of IL-10. Photochem. Photobiol. 67S, 102S.
13. Moore, K. W., A. O'Garra, R. deWaal Malefyt, P. Vieira and T. R. Mosmann (1993) Interleukin-10. Ann. Rev. Immunol. 11, 165-190.
14. Ullrich, S. E. (1994) Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation. Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J. Immunol. 152, 3410-3416.
15. Fiorentino, D. F., A. Zlotnik, P. Vieira, M. Howard, K. W. Moore and A. O'Garra (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146, 3444-3451.
16. Beissert, S., J. Hosoi, S. Grabbe, A. Asahina and R. D. Granstein (1995) IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J. Immunol. 154, 1280-1286.
17. Asadullah, K., W. Sterry, K. Stephanek, D. Jasulaitis, M. Leupold, H. Audring, H.-D. Volk and W.-D. Döcke (1998) IL-10 is a key cytokine in psoriasis. J. Clin. Invest. 101, 783-794.
18. Asadullah, K., W.-D. Döcke, Ebeling, M., M. Friedrich, G. Belbe, H. Audring, H.-D. Volk and W. Sterry (1999) Interleukin 10 treatment of psoriasis - clinical results of a phase 2 trial [Review]. Arch. Dermatol. 135, 187-192.
19. Simkin, G., J.-S. Tao, J. G. Levy and D. W. C. Hunt (2000) IL-10 contributes to the inhibition of contact hypersensitivity in mice treated with photodynamic therapy. J. Immunol. 164, 2457-2462.
20. Ullrich, S. E., B. W. McIntyre and J. M. Rivas (1990) Suppression of the immune response to alloantigen by factors released from ultraviolet-irradiated keratinocytes. J. Immunol. 145, 489-498.
21. Rivas, J. M. and S. E. Ullrich (1992) Systemic suppression of DTH by supernatants from UV-irradiated keratinocytes: an essential role for interleukin 10. J. Immunol. 149, 3865-3871.
22. de Vree, W. J., M. C. Essers, H. S. De Bruijn, W. M. Star, J. F. Koster and W. Sluiter (1996) Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo. Cancer Res. 56, 2908-2911.
23. Nseyo, U. O., R. K. Whalen, M. R. Duncan, B. Berman and S. L. Lundahl (1990) Urinary cytokines following photodynamic therapy for bladder cancer. Urology 36, 167-171.
24. Evans, S., W. Matthews, R. Perry, D. Fraker, J. Norton and H. I. Pass (1990) Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages. J. Natl. Cancer Inst. 82, 34-39.
25. Canti, G., P. Franco, O. Marelli, L. Ricci and A. Nicolin (1984) Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210). Cancer Res. 44, 1551-1556.
26. Kick, G., G. Messer, A. Goetz, G. Plewig and P. Kind (1995) Photodynamic therapy induces expression of interleukin 6 by activation of AP-1 but not NF-kB DNA binding. Cancer Res. 55, 2373-2379.
27. 6-photodynamic therapy in Buffalo rats. Neoplasma 44, 192-196.
28. Herman, S., Y. Kalechman, U. Gafter, B. Sredni and Z. Malik (1996) Photofrin II induces cytokine secretion by mouse spleen cells and human peripheral mononuclear cells. Immunopharmacology 31, 195-204.
29. Kick, G., G. Messer, G. Plewig, P. Kind and A. E. Goetz (1996) Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy. Br. J. Cancer 74, 30-36.
30. Korbelik, M., G. Krosl, J. Krosl and G. J. Dougherty (1996) The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res. 56, 5647-5652.
31. Yuspa, S. H., P. Hawley-Nelson, B. Koechler and J. R. Stanley (1993) A survey of transformation markers in differentiating epidermal cell lines. Cancer Res 40, 4694-4697.
32. Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
33. Kim, J. M., C. I. Brannan, N. G. Copeland, N. A. Jenkins, T. A. Khan and K. W. Moore (1992) Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J. Immunol. 148, 3618-3623.
34. Murphy, S. P., S. O. Gollnick, T. Paznarry and T. B. Tomasi (1997) Repressional MHC class II gene transcription in trophoblast cells by novel single stranded DNA binding proteins. Mol. Reprod. Differ. 47, 1-14.
35. Mu, J., N. Yamamoto, T. Tsutsui, X. Tai, M. Kobayashi, H. Fujiwara and T. Hamaoka (1995) Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res. 55, 4404-4408.
36. Ryter, S. W. and C. J. Gomer (1993) Nuclear factor κB binding activity in mouse L1210 cells following Photofrin II-mediated photosensitization. Photochem. Photobiol. 58, 753-756.
37. Baeuerle, P. A. and T. Henkel (1994) Function and activation of NF-κB in the immune system. Ann. Rev. Immunol. 12, 141-179.
38. Abate, C., L. Patel, F. J. Rauscher and T. Curran (1990) Redox regulation of fos and jun DNA-binding activity in vitro. Science 249, 1157-1161.
39. Xanthoudakis, S., G. Miao, F. Wang, Y. C. Pan and T. Curran (1992) Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11, 3323-3335.
40. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-2015.
41. Yao, K.-S., S. Zanthoudakis, T. Curran and P. J. O'Dwyer (1994) Activation of AP-1 and of nuclear redox factor, Ref1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell. Biol. 14, 5997-6003.
42. Luna, M. C., S. Wong and C. J. Gomer (1994) Photodynamic therapy mediated induction of early response genes. Cancer Res. 54, 1374-1380.
43. Platzer, C., C. Meisel, K. Vogt, M. Platzer and H. D. Volk (1995) Upregulation and monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 7, 517-523.
44. Rooney, J. W., M. R. Hodge, P. G. McCaffrey, A. Rao and L. H. Glimcher (1994) A common factor regulates both Th1- and Th2-specific cytokine gene expresion. EMBO J. 13, 625-633.
45. Tone, M., M. J. Powell, Y. Tone, S. A. Thompson and H. Waldmann (2000) IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3. J. Immunol. 165, 286-291.
46. Platzer, C., E. Fritsch, T. Elsner, M. H. Lehmann, H. D. Volk and S. Prosch (1999) Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur. J. Immunol. 29, 3098-3104.
47. Brightbill, H. D., S. E. Plevy, R. L. Modlin and S. T. Smale (2000) A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 164, 1940-1951.
48. Chen, Y., J. Inobe and H. L. Weiner (1997) Inductive events in oral tolerance in the TCR transgenic adoptive transfer model. Cell. Immunol. 178, 62-68.
49. Granville, D. J., C. M. Carthy, H. Jiang, J. G. Levy, B. M. McManus, J. Y. Matroule, J. Piette and D. W. C. Hunt (2000) Nuclear factor-κB activation by the photochemotherapeutic agent verteporfin. Blood 95, 256-262.
50. Naora, H. and I. G. Young (1995) Comparison of the mechanisms regulating IL-5, IL-4, and three other lymphokine genes in the Th2 clone D10.G4.1. Exp. Hematol. 23, 597-602.
51. Powell, M. J., S. A. Thompson, Y. Tone, H. Waldmann and M. Tone (2000) Posttranscriptional regulation of IL-10 gene expression through sequences in the 3′-untranslated region. J. Immunol. 165, 292-296.
52. Rivas, J. M. and S. E. Ullrich (1994) The role of IL-4, IL-10, and TNF-α in the immune suppression induced by ultraviolet radiation. J. Leukoc. Biol. 56, 769-775.
53. Shreeder, V., T. Giese, V. W. Sung and S. E. Ullrich (1998) A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol. 160, 3783-3789.